CHOP researchers develop tool to monitor disease severity in patients with mitochondrial myopathy

By | September 2, 2021
Researchers at Children’s Hospital of Philadelphia (CHOP) successfully developed and validated a new outcome measure to monitor disease severity and progression in patients with impaired skeletal muscle function caused by mitochondrial disease.